China NMPA Product Recall - Hemodialysis machine

Bellek Hexiang Medical Equipment (Shanghai) Co., Ltd. initiated a voluntary Class III recall for specific hemodialyzer products, a measure reported to the National Medical Products Administration (NMPA) and publicly announced on February 21, 2017. This recall was prompted by the company's discovery of a significant labeling discrepancy: an error in the registration certificate number displayed on the Chinese labels of certain affected product models. The main issue was an inaccurate registration certificate number on product labeling. The regulatory framework for this action falls under the NMPA, which oversees medical device safety and compliance. The classification as a Level III recall signifies that while a regulatory violation occurred, the use of or exposure to the affected hemodialyzers is considered unlikely to result in serious adverse health consequences. The required action for Bellek Hexiang was to voluntarily recall the relevant products from the market. Comprehensive details, including the precise models and batch numbers of the affected products, have been formally documented and submitted by the company in a "Medical Device Recall Event Report Form," ensuring transparency and adherence to NMPA standards.